CNBCCenter
← All coverage gaps
2026-10-09 16:17
Teva wins FDA approval for monthly schizophrenia injection Weltruza
100%
2 outlets · Left 0 · Center 2 · Right 0
Who got there first
each line: one outlet's first article — above the track left · below right · across center
First reported by Reuters (Center); 2 outlets over 1h.
Reuters · +1h CNBC
What each side is saying
- CNBCCenter
Teva has received FDA approval for once monthly injectable schizophrenia drug Weltruza. The announcement sent Teva shares gaining in premarket.
Read at cnbc.com → - ReutersCenter
Teva wins FDA approval for monthly schizophrenia injection Weltruza Reuters
Read at reuters.com →
Each blurb is the outlet's own feed summary, quoted unedited. Nothing here is generated.
2 articles, newest first · filter by side
location
Every headline that clustered into this story, newest first. Links go straight to the publisher - no article text is stored here, and the one image is an unmodified copy of the publisher's own thumbnail.